- Home
- IPHA vs HQI Comparison
IPHA vs HQI Comparison
Compare IPHA & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- HQI
- Stock Information
- Founded
- IPHA 1999
- HQI 2002
- Country
- IPHA France
- HQI United States
- Employees
- IPHA N/A
- HQI N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- HQI Professional Services
- Sector
- IPHA Health Care
- HQI Consumer Discretionary
- Exchange
- IPHA Nasdaq
- HQI Nasdaq
- Market Cap
- IPHA 148.3M
- HQI 196.4M
- IPO Year
- IPHA 2019
- HQI N/A
- Fundamental
- Price
- IPHA $1.79
- HQI $13.34
- Analyst Decision
- IPHA Strong Buy
- HQI Strong Buy
- Analyst Count
- IPHA 1
- HQI 2
- Target Price
- IPHA $11.50
- HQI $18.50
- AVG Volume (30 Days)
- IPHA 779.8K
- HQI 11.2K
- Earning Date
- IPHA 09-12-2024
- HQI 11-07-2024
- Dividend Yield
- IPHA N/A
- HQI 1.83%
- EPS Growth
- IPHA N/A
- HQI N/A
- EPS
- IPHA N/A
- HQI 0.10
- Revenue
- IPHA $36,202,722.00
- HQI $36,279,000.00
- Revenue This Year
- IPHA N/A
- HQI N/A
- Revenue Next Year
- IPHA $101.65
- HQI $8.39
- P/E Ratio
- IPHA N/A
- HQI $134.94
- Revenue Growth
- IPHA N/A
- HQI 0.28
- 52 Week Low
- IPHA $1.29
- HQI $11.39
- 52 Week High
- IPHA $3.51
- HQI $15.75
- Technical
- Relative Strength Index (RSI)
- IPHA 45.92
- HQI 44.71
- Support Level
- IPHA $1.64
- HQI $12.42
- Resistance Level
- IPHA $1.87
- HQI $13.37
- Average True Range (ATR)
- IPHA 0.12
- HQI 0.62
- MACD
- IPHA -0.04
- HQI -0.08
- Stochastic Oscillator
- IPHA 28.66
- HQI 41.44
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The primary source of revenue for the company is royalty fees based on the operation of its franchised offices.